HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Reversible posterior leukoencephalopathy syndrome in two patients with microscopic polyarteritis nodosa].

Abstract
We report here two cases (72-year-old woman, 77-year-old-woman) with perinuclear anti-neutrophil antibody (P-ANCA) positive microscopic polyarteritis nodosa (mPN). Both patients presented with generalized convulsion, consciousness disturbance and severe hypertension several days after the administration of high dose methylpredonisolone followed by oral predonisolone. CT brain scan showed hypodensity area on bilateral posterior lobes. MRI T2 weighted image and FLAIR image showed increased signal intensity on the occipital gray and white matter. Although diffusion weighted MRI disclosed slightly high signal intensity, apparent diffusion coefficient (ADC) value at the occipital gray and white matter remained normal or even elevated. These findings, which were consistent with vasogenic edema, lead us to diagnose them as suffering from reversible posterior leukoencephalopathy syndrome (RPLS). After the second administration of high dose methylpredonisolone, their symptoms and signs, together with the MRI findings, gradually improved. To our knowledge, this is the first report concerning RPLS in a patient with mPN.
AuthorsHiroyuki Kawano, En Kimura, Masatoshi Ishizaki, Yasuto Nishida, Noriko Matsumoto, Tarou Yamashita, Teruyuki Hirano, Makoto Uchino
JournalRinsho shinkeigaku = Clinical neurology (Rinsho Shinkeigaku) Vol. 42 Issue 10 Pg. 949-53 (Oct 2002) ISSN: 0009-918X [Print] Japan
PMID12739385 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Aged
  • Brain Diseases (etiology)
  • Female
  • Humans
  • Polyarteritis Nodosa (complications)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: